Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCIT for House Dust Mite Allergic Rhinitis
NCT01013116Phase 3Unknown
- Sponsor
- ROXALL Medizin GmbH
- Start
- Apr 2016
- Primary completion
- Apr 2017
- Countries
- 1
01
Overview
A Phase 3 trial of House dust mite allergen extract in allergic rhinitis (AR), sponsored by ROXALL Medizin GmbH. Status: unknown.
02
Drugs
House dust mite allergen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01013116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01013116.